TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.

H Bonnefoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.